[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 65, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.44, "dayLow": 1.39, "dayHigh": 1.45, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.44, "regularMarketDayLow": 1.39, "regularMarketDayHigh": 1.45, "payoutRatio": 0.0, "beta": -1.828, "trailingPE": 0.03469795, "forwardPE": -0.52851707, "volume": 46752, "regularMarketVolume": 46752, "averageVolume": 248596, "averageVolume10days": 107330, "averageDailyVolume10Day": 107330, "bid": 1.35, "ask": 1.47, "bidSize": 1, "askSize": 1, "marketCap": 3470552, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 30.43, "fiftyDayAverage": 1.524, "twoHundredDayAverage": 6.46942, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -89278, "profitMargins": 0.0, "floatShares": 2140959, "sharesOutstanding": 2496800, "sharesShort": 178174, "sharesShortPriorMonth": 58196, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0714, "heldPercentInsiders": 0.00018999999, "heldPercentInstitutions": 0.00204, "shortRatio": 0.67, "shortPercentOfFloat": 0.0714, "impliedSharesOutstanding": 2516940, "bookValue": 7.673, "priceToBook": 0.1811547, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -11277000, "trailingEps": 40.06, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.01, "52WeekChange": -0.8351518, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 1.39, "targetHighPrice": 34.0, "targetLowPrice": 10.0, "targetMeanPrice": 22.0, "targetMedianPrice": 22.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 3281000, "totalCashPerShare": 1.532, "ebitda": -9387000, "totalDebt": 108000, "quickRatio": 1.181, "currentRatio": 1.414, "debtToEquity": 8.963, "returnOnAssets": -1.3603799, "returnOnEquity": -4.67949, "freeCashflow": -4757375, "operatingCashflow": -8144000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "regularMarketChangePercent": -3.47223, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755301595, "regularMarketTime": 1755288001, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 3.5971274, "postMarketPrice": 1.44, "postMarketChange": 0.05000007, "regularMarketChange": -0.0500001, "regularMarketDayRange": "1.39 - 1.45", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 248596, "fiftyTwoWeekLowChange": 0.28999996, "fiftyTwoWeekLowChangePercent": 0.26363632, "fiftyTwoWeekRange": "1.1 - 30.43", "fiftyTwoWeekHighChange": -29.04, "fiftyTwoWeekHighChangePercent": -0.9543214, "fiftyTwoWeekChangePercent": -83.51518, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 40.06, "epsForward": -2.63, "epsCurrentYear": -4.045, "priceEpsCurrentYear": -0.3436341, "fiftyDayAverageChange": -0.13400006, "fiftyDayAverageChangePercent": -0.087926544, "twoHundredDayAverageChange": -5.07942, "twoHundredDayAverageChangePercent": -0.785143, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2025-08-15", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "regularMarketPrice": 1.39, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]